Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [35.174.62 ]

🍽️ ondansetron hydrochloride,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

  1. Headache: Headache is one of the most common side effects reported by individuals taking ondansetron. It may range from mild to severe and can sometimes interfere with daily activities.

  2. Constipation: Ondansetron can slow down bowel movements and lead to constipation, especially when used for an extended period. Increasing fluid intake and dietary fiber may help alleviate this side effect.

  3. Fatigue: Some people may experience fatigue or tiredness while taking ondansetron. This side effect can affect daily functioning and may require adjustments to activities or rest periods.

  4. Dizziness: Ondansetron may cause dizziness or lightheadedness in some individuals, especially when standing up quickly from a sitting or lying position. It's important to rise slowly to minimize the risk of falls.

  5. Diarrhea: While less common than constipation, some individuals may experience diarrhea as a side effect of ondansetron. This side effect is usually mild and resolves on its own in most cases.

  6. Abdominal pain: Ondansetron can sometimes cause abdominal discomfort or pain, which may include cramping, bloating, or discomfort in the stomach area.

  7. Changes in liver function: In rare cases, ondansetron may affect liver function and lead to abnormal liver enzyme levels. This side effect is more common in individuals with preexisting liver conditions.

  8. Allergic reactions: Although rare, some people may experience allergic reactions to ondansetron, including rash, itching, swelling of the face or throat, difficulty breathing, or dizziness. Seek immediate medical attention if you experience any signs of an allergic reaction.

  9. Serotonin syndrome: Ondansetron can increase serotonin levels in the brain, particularly when used in combination with other medications that affect serotonin. Serotonin syndrome is a potentially life-threatening condition characterized by symptoms such as agitation, confusion, rapid heart rate, high blood pressure, sweating, tremors, and fever.

  10. QT prolongation: Ondansetron may prolong the QT interval on an electrocardiogram (ECG), which can increase the risk of abnormal heart rhythms, including a type of arrhythmia called torsades de pointes. This risk may be higher in individuals with preexisting heart conditions or those taking other medications known to prolong the QT interval.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations   |   βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of ondansetron hydrochloride,(prescription) On Probiotics

Rank Probiotic Impact
species Escherichia coli Reduces

Bacteria Impacted by ondansetron hydrochloride,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Coprococcus genus Decreases 👪 Source Study
Roseburia genus Decreases 👪 Source Study
Mediterraneibacter genus Decreases 👪 Source Study
Bilophila genus Decreases 👪 Source Study High Level Cause Brain Fog(Cognitive impairment)
Escherichia genus Decreases 👪 Source Study
Segatella genus Decreases 👪 Source Study
Enterocloster genus Decreases 👪 Source Study
Bacteroides genus Decreases 👪 Source Study
Fusobacterium genus Decreases 👪 Source Study Periodontal disease, Lemierre syndrome, skin ulcers
Phocaeicola genus Decreases 👪 Source Study
Agathobacter genus Decreases 👪 Source Study
Parabacteroides genus Decreases 👪 Source Study BMI, fat percent,blood pressure
unclassified Robinsoniella no rank Decreases ⚗️ Source Study
unclassified Fusobacterium no rank Decreases ⚗️ Source Study
unclassified Negativicoccus no rank Decreases ⚗️ Source Study
Escherichia coli O80:H26 no rank Decreases 👶 Source Study
Eggerthellales order Decreases ⚗️ Source Study
Escherichia coli O145 serogroup Decreases 👶 Source Study
Escherichia coli O157 serogroup Decreases 👶 Source Study
Escherichia coli O26 serogroup Decreases 👶 Source Study
Escherichia coli O43 serogroup Decreases 👶 Source Study
Escherichia coli O1:H42 serotype Decreases 👶 Source Study
Escherichia coli O104:H4 serotype Decreases 👶 Source Study
Escherichia coli O121:H19 serotype Decreases 👶 Source Study
Escherichia coli O127:H6 serotype Decreases 👶 Source Study
Escherichia coli O139:H28 serotype Decreases 👶 Source Study
Escherichia coli O157:H7 serotype Decreases 👶 Source Study bloody diarrhea
Escherichia coli O44:H18 serotype Decreases 👶 Source Study
Escherichia coli O55:H7 serotype Decreases 👶 Source Study
Escherichia coli O6:H16 serotype Decreases 👶 Source Study
Escherichia coli O7:K1 serotype Decreases 👶 Source Study
Coprococcus comes species Decreases 📓 Source Study
Roseburia intestinalis species Decreases 📓 Source Study
[Ruminococcus] gnavus species Decreases 📓 Source Study
Bilophila wadsworthia species Decreases 📓 Source Study
[Ruminococcus] torques species Decreases 📓 Source Study
Bacteroides xylanisolvens species Decreases 📓 Source Study
Escherichia coli species Decreases 📓 Source Study Diarrheal disease in children and travelers, Foodborne diarrhea outbreaks, hemorrhagic colitis, hemolytic-uremic syndrome
Segatella copri species Decreases 📓 Source Study Over 70%ile Indicator of mycotoxin present
Enterocloster bolteae species Decreases 📓 Source Study
Anaerofustis stercorihominis species Decreases ⚗️ Source Study
Asaccharospora irregularis species Decreases ⚗️ Source Study
Fusobacterium nucleatum species Decreases 📓 Source Study Infectious bacteria
Negativicoccus sp. S5-A15 species Decreases ⚗️ Source Study
Paraprevotella clara species Decreases ⚗️ Source Study
Phocaeicola vulgatus species Decreases 📓 Source Study
Agathobacter rectalis species Decreases 📓 Source Study
Slackia sp. NATTS species Decreases ⚗️ Source Study
Pseudoflavonifractor capillosus species Decreases ⚗️ Source Study
[Collinsella] massiliensis species Decreases ⚗️ Source Study
Parvibacter caecicola species Decreases ⚗️ Source Study
Parabacteroides merdae species Decreases 📓 Source Study Infectious bacteria
Bacteroides uniformis species Decreases 📓 Source Study Infectious bacteria
Coriobacterineae suborder Decreases ⚗️ Source Study
Fusobacterium nucleatum subsp. nucleatum subspecies Decreases 👶 Source Study
Chlamydiae/Verrucomicrobia group superphylum Decreases ⚗️ Source Study

Impact of ondansetron hydrochloride,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.4 0.4
ADHD 0.7 0.5 0.4
Age-Related Macular Degeneration and Glaucoma 0.5 0 0
Allergic Rhinitis (Hay Fever) 1.3 1.3
Allergies 0.5 0.3 0.67
Allergy to milk products 0.6 0.3 1
Alzheimer's disease 1.1 3.1 -1.82
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.7 0.5 0.4
Ankylosing spondylitis 1 1.1 -0.1
Anorexia Nervosa 0 0.7 0
Antiphospholipid syndrome (APS) 1.4 0.4 2.5
Asthma 0.6 -0.6
Atherosclerosis 0.1 1.4 -13
Atrial fibrillation 0.7 1.1 -0.57
Autism 4 2.4 0.67
Barrett esophagus cancer 0.1 0.1
benign prostatic hyperplasia 0.2 0.2
Bipolar Disorder 0.8 1 -0.25
Brain Trauma 0.6 -0.6
Carcinoma 0.8 0.1 7
Celiac Disease 0.7 0.6 0.17
Cerebral Palsy 0.6 -0.6
Chronic Fatigue Syndrome 1.5 1.8 -0.2
Chronic Kidney Disease 2.2 1.1 1
Chronic Lyme 0.6 -0.6
Chronic Obstructive Pulmonary Disease (COPD) 0.1 1 -9
Chronic Urticaria (Hives) 0.7 0.3 1.33
Coagulation / Micro clot triggering bacteria 0.7 0.5 0.4
Colorectal Cancer 1.6 0.1 15
Constipation 0.5 0.5 0
Coronary artery disease 1 0.5 1
COVID-19 1 2.8 -1.8
Crohn's Disease 3.5 1.4 1.5
cystic fibrosis 0.7 0.6 0.17
deep vein thrombosis 0.7 0.5 0.4
Depression 1.6 2.6 -0.63
Eczema 1.1 1.1
Endometriosis 1.3 1.3
Eosinophilic Esophagitis 0.1 0.1
Epilepsy 0.4 0.2 1
Fibromyalgia 0.5 1.4 -1.8
Functional constipation / chronic idiopathic constipation 2 2.3 -0.15
gallstone disease (gsd) 0.3 0.6 -1
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.2 0.2
Generalized anxiety disorder 1.7 0.6 1.83
Gout 0.5 -0.5
Graves' disease 0.1 0.5 -4
Halitosis 0.2 0.2
Hashimoto's thyroiditis 1.5 0.6 1.5
Hidradenitis Suppurativa 0.5 0.5
Histamine Issues,Mast Cell Issue, DAO Insufficiency 1.2 0.5 1.4
hyperglycemia 0.2 0.1 1
hypersomnia 0.4 -0.4
hypertension (High Blood Pressure 0.4 1.5 -2.75
Hypothyroidism 0.5 -0.5
Hypoxia 0.1 0.1
IgA nephropathy (IgAN) 1.3 -1.3
Inflammatory Bowel Disease 1.7 2.6 -0.53
Insomnia 0.1 0.6 -5
Intelligence 0.5 0.3 0.67
Intracranial aneurysms 0.1 0.1
Irritable Bowel Syndrome 1.3 0.8 0.63
Liver Cirrhosis 1.9 1.5 0.27
Long COVID 2.9 1.7 0.71
Low bone mineral density 1 -1
Lung Cancer 0.2 0.2
ME/CFS with IBS 0.3 1.1 -2.67
ME/CFS without IBS 1 0.1 9
Metabolic Syndrome 3.3 1.8 0.83
Mood Disorders 2.6 2.6 0
Multiple Sclerosis 0.6 1.1 -0.83
Neuropathy (all types) 0.2 -0.2
neuropsychiatric disorders (PANDAS, PANS) 0.5 0.5
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0.5 0.8 -0.6
Obesity 3.6 0.7 4.14
obsessive-compulsive disorder 1 2.8 -1.8
Osteoarthritis 1.3 1.3
Osteoporosis 0.4 0.1 3
Parkinson's Disease 1.4 2.3 -0.64
Polycystic ovary syndrome 0.5 0.5 0
Postural orthostatic tachycardia syndrome 0.5 -0.5
Premenstrual dysphoric disorder 0 0
primary biliary cholangitis 0 0
Psoriasis 0.5 1.4 -1.8
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 3.2 1.2 1.67
Rosacea 0.9 0.5 0.8
Schizophrenia 1.1 1 0.1
scoliosis 0.5 0.4 0.25
Sjögren syndrome 0.6 0.3 1
Sleep Apnea 0.6 1.1 -0.83
Small Intestinal Bacterial Overgrowth (SIBO) 0.5 0.5
Stress / posttraumatic stress disorder 1.2 1.1 0.09
Systemic Lupus Erythematosus 2.3 0.5 3.6
Tic Disorder 0.2 0.3 -0.5
Tourette syndrome 0.1 -0.1
Type 1 Diabetes 1.4 0.6 1.33
Type 2 Diabetes 3.4 1.9 0.79
Ulcerative colitis 0.8 2.1 -1.63
Unhealthy Ageing 3.5 1.1 2.18

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant. [35.174.62 ]